Recent Posts

1. 

   karuna deal

   That’s low for psych, interesting.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 9:40 AM

2. 

   MOTUS users GPS tracking

   KAM's need not worry - they are hard working and out in front of customers with high frequency. Just ask Katina :)

   Pfizer

   anonymous

   Apr 26, 2024 at 9:30 AM

3. 

   BMS needs to copy Bayer's reform model

   About $70/S when Celgene acquired. Yesterday $44/S. Celgene-a stroke of genius.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 9:30 AM

4. 

   Morgan Stanley lower price target

   Does it? Feel like we could be there in a week.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 9:28 AM

5. 

   Do Managers have to ride in our cars during field rides?

   Managers here are tracked with everything. Field rides are at the top of their tracker lists. Hell they prob have a daily metrics number to go to the crapper that’s charted on a spread sheet.

   Novartis

   anonymous

   Apr 26, 2024 at 9:20 AM

6. 

   Phathom

   Q3 or Q4 depending on NERD indication.

   Biotech Startups

   anonymous

   Apr 26, 2024 at 9:18 AM

7. 

   Entresto samples. Done?

   Incorrect It's a sunk cost at this point, they aren't worried about it's success anymore. ZS will come and draw new maps for leqvio only. Anticipate a minimum of TAS 2/3 layoff and 1/3 retained. ISS and ABLs will be cut in half. Most of the...

   Novartis

   anonymous

   Apr 26, 2024 at 9:09 AM

8. + Show More